BACKGROUND: Healthcare workers (HCWs) could be at increased occupational risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections due to increased exposure. Information regarding the burden of coronavirus disease 2019 (COVID-19) epidemic in HCWs living in Mexico is scarce. Here, we aimed to explore the epidemiology, symptoms, and risk factors associated with adverse outcomes in HCWs in Mexico City. METHODS: We explored data collected by the National Epidemiological Surveillance System in Mexico City, in HCWs who underwent real-time reverse transcription polymerase chain reaction (RT-PCR) test. We explored COVID-19 outcomes in HCWs and the performance of symptoms to detect SARS-CoV-2 infection. RESULTS: As of 20 September 2020, 57 758 HCWs were tested for SARS-CoV-2 and 17 531 were confirmed (30.35%); 6610 were nurses (37.70%), 4910 physicians (28.0%), 267 dentists (1.52%), and 5744 laboratory personnel and other HCWs (32.76%). Overall, 2378 HCWs required hospitalization (4.12%), 2648 developed severe COVID-19 (4.58%), and 336 required mechanical-ventilatory support (.58%). Lethality was recorded in 472 (.82%) cases. We identified 635 asymptomatic SARS-CoV-2 infections (3.62%). Compared with general population, HCWs had higher incidence, testing, asymptomatic cases, and mortality rates. No individual symptom offers adequate performance to detect SARS-CoV2. Older HCWs with chronic noncommunicable diseases and severe respiratory symptoms were associated with higher risk for adverse outcome; physicians were at higher risk compared with nurses and other HCWs. CONCLUSIONS: We report a high prevalence of SARS-CoV-2 infection in HCWs in Mexico City. Symptoms as a screening method are not efficient to discern those HCWs with a positive PCR-RT test. Particular attention should focus on HCWs with risk factors to prevent adverse outcomes.
BACKGROUND: Healthcare workers (HCWs) could be at increased occupational risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections due to increased exposure. Information regarding the burden of coronavirus disease 2019 (COVID-19) epidemic in HCWs living in Mexico is scarce. Here, we aimed to explore the epidemiology, symptoms, and risk factors associated with adverse outcomes in HCWs in Mexico City. METHODS: We explored data collected by the National Epidemiological Surveillance System in Mexico City, in HCWs who underwent real-time reverse transcription polymerase chain reaction (RT-PCR) test. We explored COVID-19 outcomes in HCWs and the performance of symptoms to detect SARS-CoV-2 infection. RESULTS: As of 20 September 2020, 57 758 HCWs were tested for SARS-CoV-2 and 17 531 were confirmed (30.35%); 6610 were nurses (37.70%), 4910 physicians (28.0%), 267 dentists (1.52%), and 5744 laboratory personnel and other HCWs (32.76%). Overall, 2378 HCWs required hospitalization (4.12%), 2648 developed severe COVID-19 (4.58%), and 336 required mechanical-ventilatory support (.58%). Lethality was recorded in 472 (.82%) cases. We identified 635 asymptomatic SARS-CoV-2 infections (3.62%). Compared with general population, HCWs had higher incidence, testing, asymptomatic cases, and mortality rates. No individual symptom offers adequate performance to detect SARS-CoV2. Older HCWs with chronic noncommunicable diseases and severe respiratory symptoms were associated with higher risk for adverse outcome; physicians were at higher risk compared with nurses and other HCWs. CONCLUSIONS: We report a high prevalence of SARS-CoV-2 infection in HCWs in Mexico City. Symptoms as a screening method are not efficient to discern those HCWs with a positive PCR-RT test. Particular attention should focus on HCWs with risk factors to prevent adverse outcomes.
Authors: Anfal A Al Bujayr; Bashaier A Aljohar; Ghada M Bin Saleh; Khalid H Alanazi; Abdullah M Assiri Journal: J Infect Public Health Date: 2021-08-08 Impact factor: 7.537
Authors: Miguel Ángel Salazar; Leslie Chavez-Galan; Armando Castorena-Maldonado; Maribel Mateo-Alonso; Nadia Otilia Diaz-Vazquez; Ana María Vega-Martínez; José Arturo Martínez-Orozco; Eduardo Becerril-Vargas; Fernando Manuel Sosa-Gómez; Hilda Patiño-Gallegos; Delfino Alonso-Martínez; Enrique López-Segundo; Fernando Vidal; Luis Joan Velasco-González; Silvia Pérez-Pulido; Patricio Santillán-Doherty; Justino Regalado-Pineda; Jorge Salas-Hernández; Ivette Buendía-Roldán Journal: Front Public Health Date: 2021-04-13
Authors: César Pineda-Santoyo; Abraham Campos-Romero; Marco A Luna-Ruiz Esparza; Liliana E López-Luna; Martha E Sánchez-Zarate; Abraham Zepeda-González; Miguel A Fernández-Rojas; Jonathan Alcántar-Fernández Journal: Int J Environ Res Public Health Date: 2021-11-10 Impact factor: 3.390
Authors: Elizabeth Beverly; Laurie Hommema; Kara Coates; Gary Duncan; Brad Gable; Thomas Gutman; Matthew Love; Carrie Love; Michelle Pershing; Nancy Stevens Journal: PLoS One Date: 2022-02-09 Impact factor: 3.240
Authors: Daniela de la Rosa-Zamboni; Fernando Ortega-Riosvelasco; Nadia González-García; Ana Estela Gamiño-Arroyo; Guillermo Alejandro Espinosa-González; Juan Manuel Valladares-Wagner; Araceli Saldívar-Flores; Olivia Aguilar-Guzmán; Juan Carlos Sanchez-Pujol; Briseida López-Martínez; Mónica Villa-Guillén; Israel Parra-Ortega; Lourdes María Del Carmen Jamaica-Balderas; Juan José Luis Sienra-Monge; Ana Carmen Guerrero-Díaz Journal: Front Pediatr Date: 2022-06-09 Impact factor: 3.569
Authors: Cheng-Wei Liu; Nivethika Jeyakumar; Eric McArthur; Jessica M Sontrop; Daniel T Myran; Kevin L Schwartz; Manish M Sood; Peter Tanuseputro; Amit X Garg Journal: CMAJ Open Date: 2022-07-19
Authors: César Esquivel-Chirino; Yolanda Valero-Princet; Luis Alberto Gaitán-Cepeda; Carlos Hernández-Hernández; Alejandro Macías Hernández; Hugo Laparra-Escareño; José Luis Ventura-Gallegos; Delina Montes-Sánchez; Ambar Lopéz-Macay; Fernando Hernández-Sánchez; William Alves de Oliveira; José Antonio Morales-González; Daniela Carmona-Ruiz; Karol Rosen-Esquivel; Alejandro Zentella-Dehesa Journal: Medicina (Kaunas) Date: 2021-12-10 Impact factor: 2.430